Vasquez Christian 4
4 · BioAtla, Inc. · Filed Mar 12, 2026
Research Summary
AI-generated summary of this filing
BioAtla (BCAB) CFO Christian Vasquez Receives RSU Award
What Happened Christian Vasquez, Chief Financial Officer of BioAtla, was granted an award of 240,000 restricted stock units (RSUs) on March 10, 2026. The Form 4 reports the acquisition at $0.00 per share (typical for RSU grants); the filing does not state a cash payment. This is an equity award (not an open-market purchase or sale), so it reflects compensation rather than an immediate buy/sell signal.
Key Details
- Transaction date: 2026-03-10; Form 4 filed: 2026-03-12 (timely filing).
- Amount: 240,000 RSUs acquired at $0.00 per share (no immediate cash outlay).
- Shares owned after transaction: not specified in the provided filing excerpt.
- Footnote (vesting): 25% of the RSUs vest on March 10, 2027; thereafter 6.25% of the total shares vest on the last day of each May, August, November and February, subject to continued service.
- No 10b5-1 plan, tax-withholding sale, or other special codes indicated in the provided details.
Context RSUs are time-based equity awards that convert into company shares only as they vest; they do not represent an immediate market purchase and do not necessarily indicate personal buying or selling intent. The economic value will depend on BioAtla’s stock price at each vesting date.
Insider Transaction Report
- Award
Common Stock
[F1]2026-03-10+240,000→ 530,196 total
Footnotes (1)
- [F1]Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 25% of the total number of shares on March 10, 2027, and thereafter, 6.25% of the total number of shares subject to the RSU shall vest on the last day of each May, August, November and February, subject to the reporting person's continued service through the applicable vesting date.